secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0000917520-23-000017
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences enters $2.075B credit agreement, extends maturity to 2028
------------------------------------------------------------------------------

- New credit facility: $1.3B revolver and $775M term loan, total $2.075B.
- Maturity extended from Feb 2025 to Mar 24, 2028, with springing conditions.
- Interest at Term SOFR + 1.00%-1.75% or base rate; commitment fee 0.15%-0.30%.
- Proceeds used for general corporate purposes, replacing prior 2020 credit agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/0000917520-23-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/iart-20230324.htm
  HTML page:      https://secwatch.observer/filing/0000917520-23-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer